Qilian International regains Nasdaq compliance
- China-based pharmaceutical and chemical products manufacturer, Qilian International (NASDAQ:QLI) regains Nasdaq compliance after having failed to timely file its annual report for the year ended September 30, 2022.
- On April 20, 2023, the company received a second letter from Nasdaq stating that based on the April 19, 2023 filing, the company complies with the rules.
- Nasdaq now considers this matter closed.